Edition:
United States

Merrimack Pharmaceuticals Inc (MACK.OQ)

MACK.OQ on NASDAQ Stock Exchange Global Market

5.12USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$5.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,914
52-wk High
$11.70
52-wk Low
$3.35

Chart for

About

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istiratumab) and MM-310. MM-121 is a fully human monoclonal antibody that binds to the... (more)

Overall

Beta: 2.28
Market Cap(Mil.): $57.77
Shares Outstanding(Mil.): 13.34
Dividend: 10.55
Yield (%): --

Financials

  MACK.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.98 -- --
ROI: -32.49 0.60 13.80
ROE: -44.57 -2.18 15.29

Ex-Merrimack Pharmaceuticals employee gets prison for insider trading

A former Merrimack Pharmaceuticals Inc employee was sentenced on Tuesday to six months in prison after being convicted of participating in an insider trading scheme with a friend at a rival biopharmaceutical company.

Nov 13 2018

Earnings vs. Estimates